SCHEMBL12379580

SCHEMBL12379580

Cc1ccc(C(Cl)(c2ccccc2)c2cccc(C)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 10/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KCNH2 Q12809 1/20 0.44
TSHR P16473 3/20 0.42
ACHE P22303 2/20 0.42
LMNA P02545 1/20 0.42
ALOX12 P18054 1/20 0.42
CNR1 P21554 2/20 0.41
CNR2 P34972 2/20 0.41
NPSR1 Q6W5P4 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PTPN5 P54829 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11655603 0.94 KIF11 (0.47) KIF11CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL118809 0.88 TSHR (0.48) KIF11TSHRACHELMNAALOX12
SCHEMBL2484318 0.88 TSHR (0.48) KIF11TSHRACHELMNAALOX12
Chlorotriphenylmethane SCHEMBL29248291 0.85 TSHR (0.58) KIF11CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13957446 0.85 KIF11 (0.41) KIF11TSHRNPSR1SMN1; SMN2MEN1
SCHEMBL11522521 0.84 CYP1A2 (0.37) KIF11CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL11874464 0.79 TSHR (0.52) KIF11TSHRPTPN5
SCHEMBL11588689 0.78 TSHR (0.55) TSHRACHELMNAALOX12
SCHEMBL11527250 0.78 TSHR (0.55) TSHRACHELMNAALOX12
SCHEMBL11870534 0.78 KIF11 (0.47) KIF11CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003783-B2 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer STERIX LIMITED (GB) 2011-08-23 US disclosed